Tango Therapeutics stockTNGX
Tango Therapeutics trades at $20.87, 39.3% below its 52-week high (Jun 17, 2026). The price is below its 50- and 200-day averages, a downtrend. +135.6% year to date, +177.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 10, 2026.
Ratings, candles, signals and the screener for TNGX — after you log in
Open the terminalFrequently asked questions about Tango Therapeutics
What is the Tango Therapeutics stock price?
At the close on Nov 5, 2026: $20.87 (−9.97% on the day). 52-week high: $34.39 on Jun 17, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Tango Therapeutics report earnings?
The next quarterly report is on Nov 10, 2026. Last quarter, earnings per share changed −6% year over year, revenue −100%.
Does Tango Therapeutics pay dividends?
No, Tango Therapeutics does not pay dividends.
Where does Tango Therapeutics trade and how to buy it?
Ticker TNGX, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Tango Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for TNGX are in the terminal after you log in.